Live Breaking News & Updates on Clinical oncology research program

Stay informed with the latest breaking news from Clinical oncology research program on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical oncology research program and stay connected to the pulse of your community

Dr Merchán on the Role of Immunotherapy and TKI Combinations in RCC

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Miami , Florida , United-states , Jaimer-merch , Department-of-medicine , Clinical-trials-program , Clinical-oncology-research-program , Sylvester-comprehensive-cancer-center , University-of-miami-miller-school-medicine , Division-of-medical-oncology , Trials-program

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer-merch , Division-of-medical-oncology , Department-of-medicine , Clinical-trials-program , University-of-miami-health-system , Sylvester-comprehensive-cancer-center , Clinical-oncology-research-program , Medical-oncology , Trials-program , Miami-health-system , Cancers-symposium

Non–Clear Cell RCC Subtypes Require Individualized Approach to Treatment Selection

Jaime R. Merchán, MD, spotlights case studies of patients with rare non-ccRCC histologies, discussing their clinical presentation, recent data on immunotherapy and targeted treatment options for the management of these disease subtypes, and patient outcomes on these therapies.

University-of-miami , Florida , United-states , Jaimer-merch , Department-of-medicine , National-cancer-institute , University-of-miami-health-system , National-comprehensive-cancer-network , Division-of-medical-oncology , Clinical-oncology-research-program , Science-summit

Frontline IO/TKI Regimens Continue to Evolve in ccRCC

Jaime R. Merchán, MD, discusses the evolution and current role of IO/TKI regimens in advanced RCC; highlights data from the phase 3 CLEAR and KEYNOTE-426 trials supporting the use of pembrolizumab-based regimens in untreated ccRCC; and speculates on how future biomarker-driven research could improve the benefit seen with these combinations in this disease.

Florida , United-states , University-of-miami , Jaimer-merch , Clinical-oncology-research-program , Division-of-medical-oncology , Department-of-medicine , University-of-miami-health-system , Science-summit , Medical-oncology , Trials-program

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer's development.

Miami , Florida , United-states , Miller-school , American , C-ola-landgren , Craig-moskowitz , Francesco-maura , Reed-sternberg , Lisa-giulino-roth , Emily-henderson , Oncology-service-line-at-sylvester

Research Shows Whole Genome Sequencing Offers Unprecedented Look at Hodgkin Lymphoma Genetics

Research Shows Whole Genome Sequencing Offers Unprecedented Look at Hodgkin Lymphoma Genetics
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Miami , Florida , United-states , Miller-school , University-of-miami , American , Weill-cornell , C-ola-landgren , Craig-moskowitz , Francesco-maura , Reed-sternberg , Lisa-giulino-roth

Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have illuminated how treatments for multiple myeloma and other aggressive blood cancers can lead to future malignancies, called therapy-related myeloid neoplasms (tMNs).

Miami , Florida , United-states , C-ola-landgren , Benjamin-diamond , Francesco-maura , Emily-henderson , Sylvester-myeloma-research-institute , Myeloma-genomic-lab-at-sylvester , Myeloma-research-institute , Scientists-at-sylvester-comprehensive-cancer-center , Clinical-oncology-research-program